Seroepidemiological study of the exposure to Toxoplasma gondii among horses in Algeria and analysis of risk factors

对阿尔及利亚马匹弓形虫感染情况的血清流行病学研究及风险因素分析

阅读:1

Abstract

AIM: The aim of this study was to assess the seroprevalence of the Toxoplasma gondii in horses in different parts of Algeria and to determine risk factors for the infection. MATERIALS AND METHODS: A total of 736 blood samples were collected from horses of various breeds, gender, coat colors, and ages. All horses came from various farms, racecourses, and equestrian centers. The seroprevalence was investigated by three different methods: Indirect fluorescent antibody test (IFAT) as reference method, enzyme-linked immunosorbent assay (ELISA), and latex agglutination test (LAT). RESULTS: Out of the 736 sera, 178 (24.18%) were positive for IFAT, 133 (18.07%) for LAT, and 317 (43.07%) for ELISA. It was found that IFAT and LAT were in high agreement (Kappa 0.79), indicating that LAT and IFAT had similar capabilities in the detection of anti-T. gondii antibodies from horse sera. Risk factors analysis based on IFAT results indicated that the habit of the animals was significant risk factors (p≤0.05) for Toxoplasma infection. The seroprevalence was significantly higher in horses living on farms. Moreover, a higher seroprevalence was found in older animals compared to younger ones. Furthermore, the seroprevalence in females was significantly higher than that in males and gelding. Breed, coat color, and water sources are also important factors to influence the seroprevalence of T. gondii. CONCLUSION: The results indicated that T. gondii is present in horses throughout Algeria and thus represents a risk for both human and animal health. These results underline the need to increase the vigilance and the preventive measures against this disease not only to protect the horses but also to limit the spread of the parasite.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。